Science Explorer Back to mapMap
Discussion
Company · St. Petersburg · United States

Resolve Therapeutics (United States)

resolvetherapeutics.comROR OpenAlex
Research works
41
▲ 753% vs 2018-21
Citations
868
21.1 per fractional work
Top-10% rate
10.3%
all institutions 10.0%
Open access
34%
world 40%
International
18%
world 18%
Resolve Therapeutics (United States)

Not ranked overall: Resolve Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Resolve Therapeutics (United States) work in?

In 2022-now, 48% of research at Resolve Therapeutics (United States) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (28%), Environmental Science (6%). It does 1.9× the world's share of Life Sciences.

Health Sciences: 13 fractional works · 47.7% of its workMedicine: 12 fractional works · 46.3% of its workOncology: 5 fractional works · 17.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.4% of its workPathology and Forensic Medicine: 2 fractional works · 6.4% of its workGenetics: 1 fractional works · 3.5% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.8% of its workPhysiology: 0 fractional works · 1.9% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.2% of its workPharmacology: 0 fractional works · 1.2% of its workRheumatology: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.8% of its workHematology: 0 fractional works · 0.8% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.0% of its workSpeech and Hearing: 0 fractional works · 0.6% of its workRadiological and Ultrasound Technology: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.4% of its workSmall Animals: 0 fractional works · 0.4% of its workLife Sciences: 10 fractional works · 36.1% of its workBiochemistry, Genetics and Molecular Biology: 8 fractional works · 28.0% of its workMolecular Biology: 7 fractional works · 25.6% of its workGenetics: 0 fractional works · 1.7% of its workCancer Research: 0 fractional works · 0.7% of its workImmunology and Microbiology: 1 fractional works · 5.3% of its workImmunology: 1 fractional works · 5.3% of its workAgricultural and Biological Sciences: 1 fractional works · 2.3% of its workPlant Science: 0 fractional works · 1.9% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmacology: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 9.0% of its workEnvironmental Science: 2 fractional works · 6.1% of its workEcology: 1 fractional works · 2.2% of its workManagement, Monitoring, Policy and Law: 0 fractional works · 1.3% of its workEcological Modeling: 0 fractional works · 0.6% of its workPollution: 0 fractional works · 0.6% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.5% of its workNature and Landscape Conservation: 0 fractional works · 0.5% of its workEnvironmental Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 1.5% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workOcean Engineering: 0 fractional works · 0.6% of its workComputational Mechanics: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 1.0% of its workComputer Networks and Communications: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.4% of its workNumerical Analysis: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 7.2% of its workBusiness, Management and Accounting: 1 fractional works · 2.5% of its workStrategy and Management: 1 fractional works · 2.5% of its workSocial Sciences: 0 fractional works · 1.9% of its workGeography, Planning and Development: 0 fractional works · 1.2% of its workCultural Studies: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workArts and Humanities: 0 fractional works · 1.6% of its workClassics: 0 fractional works · 0.9% of its workArcheology: 0 fractional works · 0.6% of its workPsychology: 0 fractional works · 1.2% of its workSocial Psychology: 0 fractional works · 1.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKResolveTherapeutics…27fractional works, 2022-now
Life Sciences36%Physical Sciences9%Health Sciences48%Social Sciences7%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Medicine1246.3%
    2. Health Professions01.0%
    3. Veterinary00.4%
    1. Biochemistry, Genetics and Molecular Biology828.0%
    2. Immunology and Microbiology15.3%
    3. Agricultural and Biological Sciences12.3%
    4. Neuroscience00.3%
    5. Pharmacology, Toxicology and Pharmaceutics00.3%
    1. Environmental Science26.1%
    2. Engineering01.5%
    3. Computer Science01.0%
    4. Mathematics00.4%
    1. Business, Management and Accounting12.5%
    2. Social Sciences01.9%
    3. Arts and Humanities01.6%
    4. Psychology01.2%
    5. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.48× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.25× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 5.24× its world share, 1 worksImmunology and Micro…Neuroscience: 0.19× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.71× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.13× its world share, 0 worksComputer ScienceEngineering: 0.10× its world share, 0 worksEngineeringEnvironmental Science: 1.24× its world share, 2 worksEnvironmental ScienceMathematics: 0.35× its world share, 0 worksMathematicsHealth Professions: 0.39× its world share, 0 worksHealth ProfessionsMedicine: 2.41× its world share, 12 worksMedicineVeterinary: 2.62× its world share, 0 worksVeterinaryArts and Humanities: 0.54× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.77× its world share, 1 worksBusiness, Management…Economics, Econometrics and Finance: 0.04× its world share, 0 worksEconomics, Econometr…Psychology: 0.38× its world share, 0 worksPsychologySocial Sciences: 0.15× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.2×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology5.25×8 works
  2. Immunology and Microbiology5.24×1 works
  3. Veterinary2.62×0 works
  4. Medicine2.41×12 works
  5. Environmental Science1.24×2 works
  6. Business, Management and Accounting0.77×1 works
  7. Pharmacology, Toxicology and Pharmaceutics0.71×0 works
  8. Arts and Humanities0.54×0 works
  9. Agricultural and Biological Sciences0.48×1 works
  10. Health Professions0.39×0 works
  11. Psychology0.38×0 works
  12. Mathematics0.35×0 works
  13. Neuroscience0.19×0 works
  14. Social Sciences0.15×0 works
  15. Computer Science0.13×0 works
  16. Engineering0.10×0 works
  17. Economics, Econometrics and Finance0.04×0 works

Who are the top researchers at Resolve Therapeutics (United States)?

Ranked on the quality score, Daniel J. Burge, Andy T. L. Lee and Alexander Grego lead among researchers whose main affiliation is Resolve Therapeutics (United States).

  1. 1 Daniel J. Burge United States · #514,374 worldwide 5.1k citations · 32 works
  2. 2 Andy T. L. Lee United States · #837,295 worldwide 732 citations · 17 works
  3. 3 Alexander Grego United States · #1,107,709 worldwide 230 citations · 42 works
  4. 4 Nathan Humphrey United States · #2,960,286 worldwide 2 citations · 53 works
All ranked researchers at Resolve Therapeutics (United States)

What are the most cited papers from Resolve Therapeutics (United States)?

The most cited paper from Resolve Therapeutics (United States) is "A Global Deal For Nature: Guiding principles, milestones, and targets" (Eric Dinerstein, Carly Vynne, Enric Sala et al., 2019), with 809 citations. Next come "Workgroup Report: Public Health Strategies for Reducing Aflatoxin Exposure in Developing Countries" (544) and "Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I" (357).

Most cited papers
#PaperReleasedCitations
1 A Global Deal For Nature: Guiding principles, milestones, and targets Eric Dinerstein, Carly Vynne, Enric Sala et al. · Science Advances Open access 5 Apr 2019 809
2 Workgroup Report: Public Health Strategies for Reducing Aflatoxin Exposure in Developing Countries Heather M. Strosnider et al. · Environmental Health Perspectives Open access 24 Aug 2006 544
3 Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I Peter N. Schlegel, Mark Sigman, Barbara Lynn Collura et al. · Fertility and Sterility Open access 9 Dec 2020 357
4 The Emotional Needs of Infertile Couples Edward E. Wallach, Barbara Eck Menning · Fertility and Sterility Open access Oct 1980 351
5 A “Global Safety Net” to reverse biodiversity loss and stabilize Earth’s climate Eric Dinerstein, Anup R. Joshi, Carly Vynne et al. · Science Advances Open access 4 Sep 2020 350
All 61 most cited papers, with filters and sorting

Which keywords describe research at Resolve Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Tumor Microenvironment, Genomic Analysis, Epigenetics, Chromatin Remodeling, SWI/SNF Complexes and Cancer Immunotherapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 34 words, with their numbers
  1. Cancer5▲ 13×5 topics
  2. Transcriptional Regulation3▲ 61×2 topics
  3. Genomic Analysis3▲ 37×3 topics
  4. Tumor Microenvironment3▲ 22×5 topics
  5. Chromatin Remodeling2▲ 828×1 topic
  6. Epigenetics2▲ 208×2 topics
  7. SWI/SNF Complexes2▲ 828×1 topic
  8. Cancer Immunotherapy2▲ 57×2 topics
  9. Lymphoma2▲ 49×3 topics
  10. Immunotherapy2▲ 10×4 topics
  11. BET Bromodomains2▲ 221×1 topic
  12. Cancer Therapy2▲ 12×5 topics
  13. PROTACs2▲ 221×1 topic
  14. Breast Cancer2▲ 25×2 topics
  15. CAR T Cells2▲ 85×1 topic
  16. CDK4/6 Inhibitors2▲ 219×1 topic
  17. Chimeric Antigen Receptor2▲ 85×1 topic
  18. Metastatic Breast Cancer2▲ 109×2 topics
  19. Palbociclib2▲ 219×1 topic
  20. PET Imaging2▲ 35×3 topics
  21. Cell Proliferation2▲ 66×2 topics
  22. Cancer Progression1▲ 29×2 topics
  23. Inflammation1▲ 2.4×5 topics
  24. Metastasis1▲ 15×2 topics
  25. Pim Oncogenes1▲ 258×1 topic
  26. Rituximab1▲ 34×2 topics
  27. Tumorigenesis1▲ 116×1 topic
  28. Angiogenesis1▲ 13×2 topics
  29. Fibroblast Activation Protein1▲ 103×1 topic
  30. Immunosuppression1▲ 49×1 topic
  31. Prognostic Factors1▲ 10.0×6 topics
  32. Apoptosis1▲ 13×2 topics
  33. IL-61▲ 172×1 topic
  34. STAT31▲ 172×1 topic

Which research topics does Resolve Therapeutics (United States) publish most on?

By volume in 2022-now: Chromatin Remodeling and Cancer, Protein Degradation and Inhibitors, CAR-T cell therapy research and Advanced Breast Cancer Therapies.

Chromatin Remodeling and Cancer: 2 fractional worksProtein Degradation and Inhibitors: 2 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksAdvanced Breast Cancer T…2Advanced Breast Cancer Therapies: 2 fractional worksCancer Mechanisms and Therapy: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksCytokine Signaling Pathw…1Cytokine Signaling Pathways and Interactions: 1 fractional worksChronic Lymphocytic Leukemia Research: 1 fractional worksCancer-related gene regulation: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional works
Molecular BiologyOncologyPulmonary and Respiratory MedicinePathology and Forensic Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Chromatin Remodeling and Cancer Molecular Biology 2 works
  2. 2 Protein Degradation and Inhibitors Molecular Biology 2 works
  3. 3 CAR-T cell therapy research Oncology 2 works
  4. 4 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
  5. 5 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 1 works
  6. 6 Peptidase Inhibition and Analysis Oncology 1 works
  7. 7 Cytokine Signaling Pathways and Interactions Oncology 1 works
  8. 8 Chronic Lymphocytic Leukemia Research Genetics 1 works
  9. 9 Cancer-related gene regulation Molecular Biology 1 works
  10. 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.5%not open65.5%

World: 40% of research is openly available.

with international co-authors17.8%domestic only82.2%

World: 18% is written across borders.

How has Resolve Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 753% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Resolve Therapeutics (United States) as a percentage of every work published that year, 0.00016% in 2024.

still counting0.00020%0.00040%0.00060%Resolve Therapeutics (United States)0.000075% in 20251990200020102020

Fractional works of Resolve Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in St. Petersburg

All research institutions in St. Petersburg

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Resolve Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.